Lexicon Pharmaceuticals
Home
Contact Us
Site Map
About Us
About Us Home
Management Team
Board of Directors
Development Team
Locations
Contact Us
History
Pipeline
Drug Pipeline Home
Our Goal
Therapeutic Areas
Drug Development Team
Clinical Trials
Publications
Discovery
Discovery Home
Discovery Process
Technology
Genome5000
Medicinal Chemistry
Patents
Academic Access
Technology Licensing
Scientific Publications
Alliances
Alliances Home
Current Alliances
Technology Licensing
Careers
Careers Home
Opportunities
Our Culture
Benefits
Community Involvement
The Woodlands
Princeton
Awards and Recognition
News
News Home
Media Inquiries
Investors
Investors Home
Media
Events
Stock Quote
SEC Filings
Annual Reports
Corporate Governance
Request Information
News Home
Media Inquiries
Subscribe
Press Releases
Filter
Display #
5
10
15
20
25
30
50
100
All
11/24/2008
Lexicon Pharmaceuticals to Present at Two Upcoming Healthcare Conferences
11/13/2008
Lexicon's Drug Candidate LX1032 for Carcinoid Syndrome Successfully Completes Phase 1 Clinical Trials
10/30/2008
Lexicon Pharmaceuticals Reports 2008 Third Quarter Financial Results
10/25/2008
Lexicon Presents Phase 1 Clinical Trial Results for LX2931 at American College of Rheumatology Annual Meeting
08/13/2008
Lexicon Pharmaceuticals Identifies New Drug Candidate for Glaucoma
07/29/2008
Lexicon Pharmaceuticals' Drug Candidate for Irritable Bowel Syndrome Completes Phase 1 Clinical Trial Showing Positive Results
07/29/2008
Lexicon Pharmaceuticals Reports 2008 Second Quarter Financial Results
07/17/2008
Lexicon to Report Second Quarter 2008 Financial Results on July 29, 2008
06/02/2008
Lexicon's Drug Candidate for Carcinoid Syndrome Receives Fast Track Status From the FDA
05/27/2008
Lexicon Pharmaceuticals Implements Reorganization to Deploy Resources Toward Drug Development Pipeline
«
Start
Prev
1
2
3
4
5
6
7
8
9
10
Next
End
»
Page 6 of 37
